ResourceSeparations
Advantages of using ACQUITY PREMIER System and columns with MaxPeak HPS technology for bioanalysis of gefitinib
19 Feb 2021In this application note, Waters investigates the effects of novel hybrid barrier surface technologies on metal-insensitive compounds, using gefitinib (Iressa) as a candidate molecule. The ACQUITY PREMIER System and MaxPeak HPS Columns are designed to improve the robustness and reproducibility for bioanalysis of gefitinib.
Related Products
Request Quote for All Products
ACQUITY Premier System
WatersAlong with the reliability, ruggedness, high quality, and configuration flexibility you expect from the ACQUITY™ UPLC™ PLUS Series, the Waters™ ACQUITY Premier System delivers a step change in chromatographic performance, lab efficiency, and risk control.